Oleg Kononenko using the 3D bio-printer aboard the International Space Station. (Credit: Roscosmos)
MOSCOW (Roscosmos PR) — INVITRO, a leading medical company, and 3D Bioprinting Solutions biotechnology laboratory announced a successful completion of the first stage of the Magnetic 3D Bioprinter space experiment. On December 3, 2018, the Organaut bioprinter was delivered to the ISS on board the Soyuz MS-11 manned spacecraft. For the first time on orbit, cosmonaut-researcher Oleg Kononenko printed human cartilage tissue and a rodent thyroid gland using a Russian bioprinter.
The Organaut was already aboard the Soyuz MS-10 spacecraft on October 11, 2018, but its crew returned to Earth 20 minutes later after an emergency situation. The bioprinter landed in the habitation module and was significantly damaged by overload. The backup was prepared and the crew’s repeated training was organized in the shortest possible time.